OkuStim
Winner
#W2 Excellence in Business to Business
Medical Technologies

Details
Therapy begins where people retain control. For people affected by degenerative retinal diseases such as retinitis pigmentosa, treatment options are limited. OkuStim 2 sets a new benchmark: the CE-marked medical device enables the safe, precise and reliably reproducible independent use of transcorneal electrical stimulation. The headset integrates the stimulator with guided swivel units for accurate placement of filament electrodes. An electrode packaging designed as a guidance system supports intuitive magnetic application – design as a key driver of control, independence and therapy adherence.




